After the boom of Blockbuster(drugs with revenues exceeding $1B/yr) approvals in the 90’s, there has been a slowdown in the development of new drug entities (NDE). With drugs already in the market for easy to identify targets, research in academia […]
Machine learning has been touted as a potential cure-all for high drug prices. A number of leading biopharmaceutical companies like Roche have made some large bets in using artificial intelligence tools to improve drug development, but it remains to be seen if machine learning is living up to its hype.
80% of clinical trials shut down prematurely due to an inability to recruit sufficient patient numbers. Antidote is empowering patients to find relevant clinical trials, shifting the supply chain of patient enrollment.
Connected drug delivery devices are among the many digital supply chain innovations Teva has acquired to drive sales and control operational costs
Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?
